388 related articles for article (PubMed ID: 21282204)
1. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease.
Zhang L; Rajan V; Lin E; Hu Z; Han HQ; Zhou X; Song Y; Min H; Wang X; Du J; Mitch WE
FASEB J; 2011 May; 25(5):1653-63. PubMed ID: 21282204
[TBL] [Abstract][Full Text] [Related]
2. Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.
Yu R; Chen JA; Xu J; Cao J; Wang Y; Thomas SS; Hu Z
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):327-341. PubMed ID: 27897418
[TBL] [Abstract][Full Text] [Related]
3. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
[TBL] [Abstract][Full Text] [Related]
4. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
5. Targeting the myostatin signaling pathway to treat muscle wasting diseases.
Han HQ; Mitch WE
Curr Opin Support Palliat Care; 2011 Dec; 5(4):334-41. PubMed ID: 22025090
[TBL] [Abstract][Full Text] [Related]
6. Formononetin ameliorates muscle atrophy by regulating myostatin-mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease.
Liu L; Hu R; You H; Li J; Liu Y; Li Q; Wu X; Huang J; Cai X; Wang M; Wei L
J Cell Mol Med; 2021 Feb; 25(3):1493-1506. PubMed ID: 33405354
[TBL] [Abstract][Full Text] [Related]
7. Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice.
Murphy KT; Cobani V; Ryall JG; Ibebunjo C; Lynch GS
J Appl Physiol (1985); 2011 Apr; 110(4):1065-72. PubMed ID: 21270350
[TBL] [Abstract][Full Text] [Related]
8. The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease.
Dong J; Dong Y; Chen Z; Mitch WE; Zhang L
Kidney Int; 2017 Jan; 91(1):119-128. PubMed ID: 27653838
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Stat3 signaling ameliorates atrophy of the soleus muscles in mice lacking the vitamin D receptor.
Gopinath SD
Skelet Muscle; 2017 Jan; 7(1):2. PubMed ID: 28122601
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues.
Dong J; Dong Y; Dong Y; Chen F; Mitch WE; Zhang L
Int J Obes (Lond); 2016 Mar; 40(3):434-442. PubMed ID: 26435323
[TBL] [Abstract][Full Text] [Related]
11. Acupuncture plus low-frequency electrical stimulation (Acu-LFES) attenuates denervation-induced muscle atrophy.
Su Z; Hu L; Cheng J; Klein JD; Hassounah F; Cai H; Li M; Wang H; Wang XH
J Appl Physiol (1985); 2016 Feb; 120(4):426-36. PubMed ID: 26679610
[TBL] [Abstract][Full Text] [Related]
12. Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNFα/Myostatin Axis.
Li Y; Zhang F; Modrak S; Little A; Zhang H
Alcohol Clin Exp Res; 2020 Jan; 44(1):66-77. PubMed ID: 31657476
[TBL] [Abstract][Full Text] [Related]
13. Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass.
Zhang L; Pan J; Dong Y; Tweardy DJ; Dong Y; Garibotto G; Mitch WE
Cell Metab; 2013 Sep; 18(3):368-79. PubMed ID: 24011072
[TBL] [Abstract][Full Text] [Related]
14. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.
Zhang L; Wang XH; Wang H; Du J; Mitch WE
J Am Soc Nephrol; 2010 Mar; 21(3):419-27. PubMed ID: 20056750
[TBL] [Abstract][Full Text] [Related]
15. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
[TBL] [Abstract][Full Text] [Related]
16. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
17. Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease.
Thomas SS; Dong Y; Zhang L; Mitch WE
Kidney Int; 2013 Aug; 84(2):308-16. PubMed ID: 23515050
[TBL] [Abstract][Full Text] [Related]
18. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
19. Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1.
Chen MC; Chen YL; Lee CF; Hung CH; Chou TC
PLoS One; 2015; 10(11):e0143594. PubMed ID: 26600425
[TBL] [Abstract][Full Text] [Related]
20. Astragalus polysaccharide suppresses skeletal muscle myostatin expression in diabetes: involvement of ROS-ERK and NF-κB pathways.
Liu M; Qin J; Hao Y; Liu M; Luo J; Luo T; Wei L
Oxid Med Cell Longev; 2013; 2013():782497. PubMed ID: 24454989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
